OpenEvidence’s Miami Move Just Became a Bigger Test for AI in Cancer Care
OpenEvidence has teamed up with the Society of Surgical Oncology, moving to integrate the group’s surgical cancer-care resources into its medical AI platform. The deal also includes a $100,000 grant earmarked for surgeon-led research, a fresh step as the company extends its reach into specialty medicine.